Alnylam Pharmaceuticals Inc. (ALNY) 12-Month Stock Forecast & Price Target Cone

$174.00 -25.13% NASDAQ • Public Delayed / 60s Snapshot

Alnylam Pharmaceuticals Inc. (ALNY) carries a Roarable Rating of C (Hold) with 64/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.

ROARABLE C • HOLD / WATCH Cap $23.28B
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERHOLD / WATCH • C
025507510064
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw C · Rk C+
Cash (17)Whales (8)SEC (16)Macro (11)CEO (12)
Each axis scored 0–20
12M PRICE TARGET CONE+2.7% Base Target
$504 Bull$179 Base$139 Bear
🔴 SUNDAY NIGHT PREP • 7:00 PM ET
WHALE OPTIONS TUG-OF-WAR:38% Call Buyers ($1.7M)
62% PutsMax Pain: $171.00
INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your ALNY Position Size: $10,000

Shares at $174.00: 57.5 sh
$1,000$10,000$25,000$50,000$100,000
12M Bear Case FloorTarget $139.39
$8,011
$-1,989 (-19.9%)
12M Consensus BaseTarget $178.70
$10,270
+$270 (+2.7%)
12M Bull Case BreakoutTarget $503.78
$28,953
+$18,953 (+189.5%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100
● Strong Buy / Buy: 17● Hold: 9● Sell: 2
Wall Street FirmStance12M Target1Y AccuracyTrack Grade
Morgan StanleyInstitutional Equity DeskHOLD$18674%A
Goldman SachsSector Coverage LeadBUY$47469%B
JP MorganUS Large-Cap ResearchHOLD$15958%C
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk

Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live ALNY Tape Review)

  • ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
  • ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
  • ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
ALNY // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -46.69%▼ DESCENDING CHANNEL
2026-10-30O $172.7H $180.6L $163.3C $165.0VOL 7.05M
RES: $246.9SUP: $95.62SMA50: $236.5SMA200: $285.5
$409.1$342.5$275.9$209.2$142.6RES $246.9SUP $95.62$165.02026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ALNY Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
47.6%/yr Implied 5Y Growth

vs. +65.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ALNY today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ALNY. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ALNY today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

ALNY Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is ALNY's 12-month stock price target?

Alnylam Pharmaceuticals Inc. (ALNY) carries a 12-month consensus base price target of $178.7 (+2.7% from $174.00), with a bull-case target of $503.78 and a bear-case floor of $139.39.

Is ALNY stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates ALNY C (Hold — HOLD) with an RQD Confidence score of 64/100.